Source control in sepsis

Contents

Overview

Source control refers to all physical measures taken to eliminate the nidus of infection in sepsis — draining abscesses, debriding infected tissue, removing infected devices, and repairing perforated viscera. The Surviving Sepsis Campaign (SSC) guidelines identify source control as one of the most critical and time-sensitive interventions in sepsis, on a par with antibiotics and haemodynamic resuscitation. Antimicrobials suppress infection but cannot control established collections or necrotic tissue — source control addresses what antibiotics cannot.

Principles of Source Control

Identify the source: The specific anatomical site of infection determines the most appropriate source control intervention. Common sources in ICU sepsis include intra-abdominal collections, lung (where source control is primarily directed at the infecting organism rather than surgical intervention), urinary tract (remove/replace urinary catheter, relieve obstruction), biliary (percutaneous cholecystostomy or ERCP), intravascular devices, and soft tissue (necrotising fasciitis).

Choose the least invasive effective intervention: Where both surgical and percutaneous drainage achieve adequate control, percutaneous drainage carries lower perioperative risk and should be preferred.

Early intervention: Source control should be achieved as early as physiologically possible. Delay allows ongoing bacterial seeding, worsening sepsis, and increasing haemodynamic instability that eventually makes intervention prohibitively risky.

Do not delay source control waiting for optimisation: There is a critical misconception that patients must be optimised before intervention. In many cases, adequate source control is required for haemodynamic improvement — attempting prolonged stabilisation before removing the source perpetuates the underlying process.

Timing of Source Control

The SSC guidelines recommend source control as soon as possible, ideally within 6–12 hours of diagnosis — or sooner when the source requires immediate intervention (e.g., necrotising fasciitis, perforated viscus).

Delays in source control for intra-abdominal sepsis are independently associated with increased mortality. A large retrospective analysis of abdominal sepsis found that each hour of delay in surgical source control was associated with an incremental increase in 30-day mortality.

However, timing must be individualised:

  • Surgical intervention in an unstable patient with profound coagulopathy, hypoxaemia, or haemodynamic collapse carries extreme perioperative risk
  • Briefresuscitation — correcting the most critical physiological derangements — improves operative risk without compromising outcomes
  • "Damage control" principles apply: minimal but adequate source control in the unstable patient, with definitive repair deferred

Source Identification

Clinical history and examination: Site of pain, localising symptoms (dysuria, right upper quadrant pain, purulent drainage), examination findings (peritonism, wound erythema, crepitus), indwelling device history.

Microbiology: Blood cultures (two sets before antibiotics where possible), urine culture, wound swabs, sputum, ascitic fluid (if present), and any accessible collection. Cultures guide de-escalation once source control is achieved.

Imaging:

  • CT abdomen/pelvis with contrast: gold standard for identifying intra-abdominal collections, abscesses, free air, bowel perforation. Performed urgently in haemodynamically stable patients with suspected intra-abdominal sepsis.
  • Ultrasound: rapid bedside assessment for biliary disease (gallstones, cholecystitis), pelvic abscess, hepatic collections, soft tissue collections. Limited by patient body habitus, bowel gas, dressings.
  • CXR and CT chest: pneumonia, empyema, lung abscess.
  • Echocardiography: endocarditis (vegetations on valve leaflets), intracardiac abscess.

Interventional Options

Percutaneous drainage: Image-guided (ultrasound or CT) needle aspiration or drain insertion for localised collections. Appropriate for single, well-defined, accessible collections. Minimally invasive; can be performed under sedation in unstable patients.

Endoscopic intervention: ERCP with sphincterotomy and stenting for biliary obstruction and cholangitis; endoscopic drainage of pancreatic collections (walled-off necrosis).

Surgical drainage and debridement: Required when collections are not accessible percutaneously, when multiple or diffuse collections are present, when the source requires surgical repair (perforated viscus, ischaemic bowel), or when minimally invasive approaches have failed. Laparoscopy is preferred when technically feasible; laparotomy for unstable patients or complex anatomy.

Device removal: Central venous catheters, urinary catheters, and prosthetic material (joint replacements, vascular grafts, cardiac devices) that are the source of infection should be removed. For intravascular devices: remove and replace to a new site (never rewire over an infected device unless there is no alternative).

Necrosectomy: Removal of infected pancreatic necrosis (infected walled-off necrosis, IPN) or soft tissue necrosis. Best practice has evolved from open surgical necrosectomy to a "step-up" approach: CT-guided percutaneous drainage → minimally invasive retroperitoneal drainage (MIRD) or endoscopic necrosectomy → open surgery only if all else fails. The PANTER and TENSION trials demonstrated the superiority of step-up approaches over early open surgery for infected pancreatic necrosis.

Common Sources and Their Management

Intra-abdominal abscess: CT-guided percutaneous drainage for localised abscess. Surgical drainage if multiloculated, anatomically inaccessible, or if patient requires laparotomy for the underlying condition (anastomotic leak, perforated appendix, diverticular perforation).

Biliary sepsis / acute cholangitis: Urgent biliary decompression — ERCP with sphincterotomy and biliary stenting is the preferred technique. Percutaneous transhepatic cholangiopancreatography (PTC) if ERCP fails or is unavailable. Emergency cholecystectomy for perforated cholecystitis if septic; percutaneous cholecystostomy in the very high-risk patient as a bridge.

Urinary source: Remove or replace urinary catheter; relieve obstruction (ureteric stent or nephrostomy for obstructive uropathy).

Necrotising soft tissue infection: Surgical emergency. Early, aggressive, and repeated surgical debridement is essential. Delay is fatal. Gram stain and culture of debrided tissue guide antimicrobial therapy. Broad-spectrum cover (meropenem + clindamycin + linezolid or vancomycin) pending microbiology. Hyperbaric oxygen is used in some centres as an adjunct.

Infected intravascular device: Remove CVC and resite to a new location. In endocarditis with prosthetic valve, valve replacement may be required. For infected arteriovenous fistulae or grafts, surgical removal or excision of the infected segment.

Lung abscess: Primary treatment is prolonged antibiotics (6–8 weeks); percutaneous or endoscopic (bronchoscopic) drainage if no response or if very large (>6 cm). Surgery (lobectomy) for failure of medical and drainage management.

Viva Questions

What is source control and why is it important in sepsis management?

Source control refers to all physical measures directed at eliminating the anatomical source of infection in sepsis — draining purulent collections, debriding infected necrotic tissue, removing infected devices, and repairing the anatomical disruption causing ongoing bacterial seeding. It is a critical component of sepsis management for a fundamental reason: antibiotics suppress bacterial replication but cannot penetrate well into avascular or necrotic tissue, clear established collections, or remove biofilm-colonised devices. Without source control, ongoing bacterial seeding maintains the inflammatory drive of sepsis and prevents haemodynamic improvement regardless of antibiotic choice or haemodynamic support. The Surviving Sepsis Campaign identifies source control as one of the first-hour and first-day priorities, alongside blood cultures, antibiotics, and resuscitation. Delayed source control in intra-abdominal sepsis is independently associated with increased mortality, with each hour of delay contributing to harm.

When would you choose percutaneous drainage over surgical drainage for an intra-abdominal collection?

Percutaneous image-guided drainage is preferred when the collection is single, well-defined, and in an accessible anatomical location — when a drain can be placed safely without traversing bowel, major vessels, or other critical structures. It carries substantially lower perioperative risk than open or laparoscopic surgery, can be performed under sedation or minimal anaesthesia, and is therefore appropriate even in physiologically compromised patients who would not tolerate a general anaesthetic. Surgical drainage is necessary when the collection is multiloculated and cannot be adequately drained percutaneously, when the source requires surgical repair (perforated viscus, ischaemic bowel), when there is diffuse peritoneal contamination rather than a localised collection, or when a previous percutaneous approach has failed. The step-up approach — percutaneous first, escalating to minimally invasive surgical and then open surgical drainage only if needed — has been validated in infected pancreatic necrosis (PANTER trial) and has reduced overall complication rates. Multidisciplinary decision-making involving surgery, interventional radiology, and critical care is important in complex cases.

How do you manage necrotising soft tissue infection in the ICU?

Necrotising soft tissue infection (NSTI) — which includes necrotising fasciitis, Fournier's gangrene, and clostridial myonecrosis — is a surgical emergency with mortality of 20–40% even with optimal management. Delay in diagnosis and surgical intervention is the most important modifiable predictor of death. The LRINEC score (Laboratory Risk Indicator for Necrotising Fasciitis) can support clinical suspicion, but a negative score does not exclude the diagnosis, and clinical suspicion should drive decision-making. In a patient with severe pain out of proportion to clinical signs, crepitus, rapidly advancing skin changes, or systemic sepsis from a skin/soft tissue source, urgent surgical review and theatre preparation should occur simultaneously, not sequentially. Definitive management is surgical debridement — aggressive resection of all infected and necrotic tissue until viable bleeding margins are reached. This typically requires return to theatre at 24–48 hours and further debridements until the infection is controlled. Reconstruction and wound closure are deferred until the infection is fully controlled. In the ICU, ongoing management includes broad-spectrum antibiotics (typically meropenem + clindamycin to inhibit toxin production, + vancomycin for MRSA cover), haemodynamic support, nutritional support for the hypermetabolic catabolic state, and consideration of hyperbaric oxygen at centres with this capability. Clostridial gas gangrene (Clostridium perfringens) is a subtype requiring particular urgency and the addition of high-dose benzylpenicillin.